Back
Regional Management Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
57
RM
Regional Management
Last Price:
32.66
Seasonality Move:
2.46%
Buy
53
ANIP
ANI Pharmaceuticals
Last Price:
61.55
Seasonality Move:
0.29%
Buy
57
Regional Management (RM)
is a Buy
Is Regional Management a Buy, Sell or Hold?
- The current Regional Management [RM] share price is $32.20. The Score for RM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- RM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.05. The Score for ANIP is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RM Stock Price Chart
What is Regional Management's stock price today?
-
The Regional Management share price today is $32.20
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RM is experiencing selling pressure, which indicates risk of future bearish movement.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing slight selling pressure.
RM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.38 | Buy |
Relative Strength Index (14 RSI): | 52.64 | Buy |
Chaikin Money Flow: | -18521 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.05 - 32.83) | Buy |
Bollinger Bands (100): | (27.43 - 31.61) | Buy |
ANIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.84 | Sell |
Relative Strength Index (14 RSI): | 52.65 | Buy |
Chaikin Money Flow: | -163397 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.84 - 62.92) | Buy |
Bollinger Bands (100): | (59.73 - 65.45) | Sell |
RM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.04 | Buy |
20-day SMA: | 32.12 | Buy |
50-day SMA: | 31.07 | Buy |
200-day SMA: | 26.95 | Buy |
8-day EMA: | 32.26 | Sell |
20-day EMA: | 31.96 | Buy |
50-day EMA: | 31.01 | Buy |
200-day EMA: | 28.39 | Buy |
ANIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.54 | Buy |
20-day SMA: | 60.34 | Buy |
50-day SMA: | 61.2 | Sell |
200-day SMA: | 61.23 | Sell |
8-day EMA: | 58.88 | Buy |
20-day EMA: | 59.62 | Buy |
50-day EMA: | 60.85 | Buy |
200-day EMA: | 60.54 | Buy |
Regional Management Earnings Growth & RM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.30 per share, an increase this year of $1.55 per share, and an increase next year of $1.26 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.40 per share, an increase this year of $0.29 per share, and an increase next year of $0.99 per share.
Regional Management Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ANI Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |